Principal Securities’s Integra LifeSciences IART Stock Holding History

Principal Securities’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-82	Closed	-$1.86K	–	3783
2025 Q1	$1.86K	Hold	82	–	–	﹤0.01%	3066
2024 Q4	$1.86K	Hold	82	–	–	﹤0.01%	3060
2024 Q3	$1.49K	Hold	82	–	–	﹤0.01%	3036
2024 Q2	$2.39K	Hold	82	–	–	﹤0.01%	2859
2024 Q1	$2.91K	Hold	82	–	–	﹤0.01%	2765
2023 Q4	$3.57K	Buy	+82	New	+$3.23K	﹤0.01%	2651

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Principal Securities's IART Position: Q2 2025 in Review

Principal Securities sold out of Integra LifeSciences (IART) in Q2 2025, closing a stake of 82 shares — an estimated $1.86K sold.

Principal Securities first reported a position in IART in Q4 2023 and held it in 6 quarters. The position peaked at $3.57K in Q4 2023. 208 funds tracked by Wall St. Rank hold IART as of Q2 2025.

Principal Securities reported no remaining Integra LifeSciences position as of Q2 2025 after selling out during the quarter.
Principal Securities sold 82 Integra LifeSciences shares in Q2 2025, an estimated $1.86K.
Principal Securities first reported a position in Integra LifeSciences in Q4 2023 and held it in 6 quarters.
Principal Securities's Integra LifeSciences position peaked at $3.57K in Q4 2023.
208 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2025.

Based on Principal Securities's 13F filing for Q2 2025, filed 11 Aug 2025.